Zdrowie i gospodarka · 30/04/2024
FDA Expands Safety Testing for Human Allogeneic Cells in Cell-Based Medical Products
The FDA has released a draft guidance document outlining recommendations for determining the appropriate cell safety testing for allogeneic cell-based medical products, which may include treatments for various medical conditions.
Source: Federal Register — Food and Drug AdministrationOpen original release →